Cleveland bio labs is definitely not sitting still. Had a look at their results. 85 to 100% survival is some NHP groups. They used both males and females. That was from 2015. Zami stated they lost two years of advancement deciding to build manufacturing facilities. Imagine if we did it the other way around and were two years farther ahead. Will it pay off? I'm sure we will find out in the next couple quarters.
News 
Market Data 
Discover 
AI
